Overexpression of long non-coding RNA H19 is associated with unfavorable prognosis in patients with colorectal cancer and increased proliferation and migration in colon cancer cells.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28781681)

Published in Oncol Lett on June 15, 2017

Authors

Shan-Wen Chen1, Jing Zhu1, Ju Ma1, Jun-Ling Zhang1, Shuai Zuo1, Guo-Wei Chen1, Xin Wang1, Yi-Sheng Pan1, Yu-Cun Liu1, Peng-Yuan Wang1

Author Affiliations

1: Division of General Surgery, Peking University First Hospital, Peking University, Beijing 100034, P.R. China.

Articles cited by this

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27

Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol (2010) 24.32

Evolution and functions of long noncoding RNAs. Cell (2009) 17.54

Parental imprinting of the mouse H19 gene. Nature (1991) 5.13

The updated incidences and mortalities of major cancers in China, 2011. Chin J Cancer (2015) 2.85

Systemic treatment of colorectal cancer. Gastroenterology (2008) 2.62

Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis (2009) 2.45

Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget (2014) 2.31

The murine H19 gene is activated during embryonic stem cell differentiation in vitro and at the time of implantation in the developing embryo. Development (1991) 2.17

H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem (2005) 2.04

The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget (2015) 1.78

Role of human noncoding RNAs in the control of tumorigenesis. Proc Natl Acad Sci U S A (2009) 1.76

Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res (2007) 1.65

H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol (2014) 1.65

Identification of the long non-coding RNA H19 in plasma as a novel biomarker for diagnosis of gastric cancer. Sci Rep (2015) 1.55

Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull (2002) 1.53

Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction. Epigenetics (2010) 1.48

Long non-coding RNA expression profile in human gastric cancer and its clinical significances. J Transl Med (2013) 1.43

Regulation of the mammalian epigenome by long noncoding RNAs. Biochim Biophys Acta (2008) 1.42

The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma. Mol Pathol (2000) 1.41

The E-cadherin adhesion molecule and colorectal cancer. A global literature approach. Anticancer Res (2009) 1.36

Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta (2014) 1.35

H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b. Oncotarget (2015) 1.07

Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Biochim Biophys Acta (2002) 1.06

Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma. J Appl Oral Sci (2015) 0.86

Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis. Cytoskeleton (Hoboken) (2014) 0.85

1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Biochem Biophys Res Commun (2015) 0.85